WHO ICTRP trial

Evaluating a rapid on-site test for the monitoring of infliximab trough levels…

NL-OMON43725 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON43725
Public title Evaluating a rapid on-site test for the monitoring of infliximab trough levels- a pilot study
Scientific title Evaluating a rapid on-site test for the monitoring of infliximab trough levels- a pilot study - Evaluation of a rapid lateral-flow assay for infliximab
Primary sponsor Leids Universitair Medisch Centrum
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Observational invasive
Countries The Netherlands
Conditions crohn's disease Inflammatory bowel disease;10017969;crohn's disease;Inflammatory bowel disease
Interventions ;biological;inflammatory bowel disease;infliximab;Therapeutic drug monitoring
Registration date Apr 14, 2016
Target size 70
Secondary IDs NL52468.058.15
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations